Viewing Study NCT00077558


Ignite Creation Date: 2025-12-25 @ 12:20 AM
Ignite Modification Date: 2026-01-01 @ 5:18 PM
Study NCT ID: NCT00077558
Status: COMPLETED
Last Update Posted: 2010-03-10
First Post: 2004-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module